Table 1

Relationship between Bax expression, Bcl-2 expression the expression of VEGF, Cytochrome-c, Caspase-3, or MMP-9 and T stage or N stage
Patients (n) VEGF Cy-c Casp-3 MMP-9 Bax expression Bcl-2 expression
<10%--->10% <10%--->10%
T0 7 129.7 ± 67.7 68.3 ± 54.6 0.22 ± 0.1 488.6 ± 405.1 1(14)----6(86) 4(29)-----3(20)
T2-T3 22 516.51 ± 69.63 54.48 ± 28.85 0.07 ± 0.043 1166.6 ± 745.9 18(82)--4(18) 10(71)---12(80)
P value 0.051 0.72 0.19 0.04 0.001 0.59
<10%--->10% <10%--->10%
No 19 381.4 ± 631.1 61.2 ± 38.6 0.12 ± 0.2 991.4 ± 803.6 11(58)---8(42) 10(71)---9(60)
N(+) 10 528.67 ± 531.40 50.28 ± 28.15 0.06 ± 0.47 1064.97 ± 620.8 8(80)-----2(20) 4(29)-----6(40)
P value 0.20 0.68 0.21 0.50 0.23 0.52

Units: VEGF, pg/ml; Cy-c: Cytochrome-c, ng/ml; Casp-3: Caspase-3, pmol AMC/min/mg; MMP-9, ng/ml.

*Numbers in parentheses indicate percentages.

Kurt et al.

Kurt et al. BMC Clinical Pathology 2012 12:27   doi:10.1186/1472-6890-12-27

Open Data